New oral protease-activated receptor 4 antagonist BMS-986120: tolerability, pharmacokinetics, pharmacodynamics, and gene variant effects in humans.Merali S et al.Platelets 2022. > Plus

Unified gene expression signature of novel NPM1 exon 5 mutations in acute myeloid leukemia.Lisi V et al.Blood Adv 2022. > Plus

3D chromatin remodeling potentiates transcriptional programs driving cell invasion.Lebeau B et al.Proc Natl Acad Sci U S A 2022. > Plus